Thursday, September 06, 2018 8:32:52 PM
https://www.thestreet.com/amp/investing/stocks/allergan-botox-in-very-strong-position-14702922
Additional competition may loom for Botox, but Allergan plc (AGN) management isn't worried.
"We are in a very highly competitive marketplace already, and the fact that one or two additional toxins are coming to the United States is certainly important for us," Allergan chairman, president and CEO Brent Saunders said Wednesday, Sept. 5, at the Wells Fargo Healthcare Conference in Boston. "We take it very seriously, but it's not new."
In the U.S, Botox Cosmetic competes with Galderma SA's Dysport and Merz Pharma GmbH & Co. KGaA's Xeomin. Galderma is a unit of Nestlé SA. The product also has several competitors outside the U.S.
Upcoming domestic competition includes Revance Therapeutics Inc.'s (RVNC) RT002 and Evolus Inc.'s (EOLS) DWP-450.
A day before Saunders' conference appearance, Goldman, Sachs & Co. analysts wrote in a note that Botox's 70% market share "could come under pressure in an increasingly competitive environment."
And even if Dublin-based Allergan maintained its market share, "we believe they could lose pricing power (greater discounts potentially), impacting margins as they compete with several lower cost alternatives," Goldman analysts wrote.
Saunders at the conference, however, said the entrance of more competition could enlarge the market.
"I think the fact that there will be four or five potential neuromodulators on the market in the U.S. is probably a good thing for the overall market because our penetration in this market is in the single-digits. This market should expand significantly," he said.
Saunders added physicians, healthcare providers and practitioners will continue to have Botox among the neurotoxins in their offices.
"They are not going to stock five or six toxins," Saunders said. "We don't see that phenomena anywhere in the world. They're going to continue to stock two or three, which is what they do today all over the world, and Botox, it will always be will amongst those two or three, and so the competition will be for that second and third or fourth slot in any office."
In the second quarter, Botox Cosmetic had net revenue of $236.5 million in the U.S., up 12.5% from 2017. It had international net revenue of $171.4 million, representing a 14.1% rise year over year, excluding the impact of foreign exchange.
Allergan shares on Wednesday afternoon were up 0.1% to $190.24. The stock is up 16.3% in 2018 but down 15% over the past 12 months.
Start, and end, your trading day right with TheStreet's 'Daily Snapshot' on your favorite smart speaker. Learn more about TheStreet's market coverage for your trusted smart speaker.
Recent RVNC News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:15:36 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/16/2024 09:01:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:06:45 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 09/05/2024 09:27:28 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 09/05/2024 08:45:25 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 08/13/2024 01:29:06 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/12/2024 09:18:26 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of Revance Therapeutics, Inc. • PR Newswire (US) • 08/12/2024 07:18:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 01:20:58 PM
- Crown Laboratories and Revance Announce Entry Into Merger Agreement • PR Newswire (US) • 08/12/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 01:00:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:34:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:07:57 PM
- Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 08/08/2024 08:05:00 PM
- Revance to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • Business Wire • 08/01/2024 08:05:00 PM
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/14/2024 08:05:00 PM
- Revance to Participate in Upcoming Investor Conferences • Business Wire • 05/28/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:33:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
- Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 05/09/2024 08:06:00 PM
- Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia • Business Wire • 05/09/2024 08:05:00 PM
- Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 • Business Wire • 05/02/2024 08:05:00 PM
- Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting • Business Wire • 04/12/2024 12:00:00 PM
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/27/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:33:10 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM